Menu

Markets

Research

News

Learn
Paper trading
AI Chat
WatchlistsPortfoliosAlerts
Sign in

TC Biopharm (Holdings) Plc TCBP

Set alert

Price alert · TCBP

All alert types
0.50 USD 0.00 0.00%

At close · Mar 21

0.50 Day range 1.51
0.436 52-week range 41.50
YTD
0.00%
1 year
0.00%
Open
1.51
Prev close
0.50
Mkt cap
5.22M
Vol
5.90M
Avg vol
1.69M
EPS
-294.87
P/E
0.00
Div yield
0.00%
More statistics
Low
0.50
High
1.51
Forward P/E
-0.14
Beta
0.25
Short ratio
0.02
Inst. own
7.01%
Dividend
0.00
Ex-div date
Earnings
May 6, 2024
50-d avg
1.47
200-d avg
7.74
1y target
3.00

5D chart

Chart tools
Interval
1m5m15m30m

Chart is warming up

The five-day price history for TCBP has not been loaded yet. Try again in a moment.

Financial health

Altman Z-Score

-14.68 Distress zone

Bankruptcy-risk model: below 1.81 distress, above 2.99 safe.

Piotroski F-Score

2 / 9 Weak

Nine pass/fail tests of profitability, leverage and efficiency.

Valuation

P/E -2.1×
FY 2019: -119×FY 2020: -136×FY 2021: 0.0×FY 2022: -26.5×FY 2023: -2.1×
FY 2019 5y median -26.5× FY 2023
P/S 0.0×
FY 2019: 209×FY 2020: 352×FY 2021: 0.0×FY 2022: 9.1×FY 2023: 0.0×
FY 2019 5y median 9.1× FY 2023
P/B 4.6×
FY 2019: -283×FY 2020: -208×FY 2021: 0.0×FY 2022: 106×FY 2023: 4.6×
FY 2019 5y median 0.0× FY 2023
P/FCF -1.2×
FY 2019: -82.0×FY 2020: -201×FY 2021: 0.0×FY 2022: -2.3×FY 2023: -1.2×
FY 2019 5y median -2.3× FY 2023
EV/EBITDA -0.9×
FY 2019: -126×FY 2020: -133×FY 2021: -1.4×FY 2022: 7.3×FY 2023: -0.9×
FY 2019 5y median -1.4× FY 2023
EV/Sales 0.0×
FY 2019: 210×FY 2020: 353×FY 2021: 7.2×FY 2022: 8.5×FY 2023: 0.0×
FY 2019 5y median 8.5× FY 2023
FCF Yield -86.5%
FY 2019: -1.2%FY 2020: -0.5%FY 2021: 0.0%FY 2022: -44.4%FY 2023: -86.5%
FY 2019 5y median -1.2% FY 2023

Profitability

Gross Margin 0.0%
FY 2019: 100.0%FY 2020: 100.0%FY 2021: 100.0%FY 2022: 100.0%FY 2023: 0.0%
FY 2019 5y median 100.0% FY 2023
Operating Margin 0.0%
FY 2019: -193.8%FY 2020: -348.1%FY 2021: -368.3%FY 2022: -314.3%FY 2023: 0.0%
FY 2019 5y median -314.3% FY 2023
Net Margin 0.0%
FY 2019: -177.1%FY 2020: -275.8%FY 2021: -686.1%FY 2022: -34.2%FY 2023: 0.0%
FY 2019 5y median -177.1% FY 2023
ROE -220.0%
FY 2019: 239.0%FY 2020: 163.1%FY 2021: 82.0%FY 2022: -396.5%FY 2023: -220.0%
FY 2019 5y median 82.0% FY 2023
ROIC -246.6%
FY 2019: -87.6%FY 2020: -160.9%FY 2021: 132.5%FY 2022: -168.3%FY 2023: -246.6%
FY 2019 5y median -160.9% FY 2023
ROA -66.1%
FY 2019: -59.8%FY 2020: -75.1%FY 2021: -169.2%FY 2022: -11.6%FY 2023: -66.1%
FY 2019 5y median -66.1% FY 2023

Growth (YoY)

Revenue -100.0%
FY 2019: 0.0%FY 2020: -42.3%FY 2021: 0.0%FY 2022: 94.3%FY 2023: -100.0%
FY 2019 FY 2023
Operating Income -17.8%
FY 2019: 0.0%FY 2020: -3.7%FY 2021: -5.8%FY 2022: -65.8%FY 2023: -17.8%
FY 2019 FY 2023
EPS (diluted) 51.0%
FY 2019: 0.0%FY 2020: 14.8%FY 2021: 100.0%FY 2022: 0.0%FY 2023: 51.0%
FY 2019 FY 2023
Free Cash Flow 31.4%
FY 2019: 0.0%FY 2020: 60.4%FY 2021: -61.6%FY 2022: -177.3%FY 2023: 31.4%
FY 2019 FY 2023

Financial Health

Current Ratio 1.2×
FY 2019: 1.1×FY 2020: 0.5×FY 2021: 0.2×FY 2022: 0.8×FY 2023: 1.2×
FY 2019 5y median 0.8× FY 2023
Quick Ratio 1.2×
FY 2019: 1.1×FY 2020: 0.5×FY 2021: 0.2×FY 2022: 0.8×FY 2023: 1.2×
FY 2019 5y median 0.8× FY 2023
Debt / Equity 0.7×
FY 2019: -1.2×FY 2020: -0.8×FY 2021: -1.0×FY 2022: 7.4×FY 2023: 0.7×
FY 2019 5y median -0.8× FY 2023
Net Debt / EBITDA 0.0×
FY 2019: -0.4×FY 2020: -0.3×FY 2021: -1.4×FY 2022: -0.5×FY 2023: 0.0×
FY 2019 5y median -0.4× FY 2023
Interest Coverage 0.0×
FY 2019: -24.1×FY 2020: -23.6×FY 2021: -2.1×FY 2022: -1.8×FY 2023: 0.0×
FY 2019 5y median -2.1× FY 2023

Dividends

Dividend Yield 0.0%
FY 2019: 0.0%FY 2020: 0.0%FY 2021: 0.0%FY 2022: 0.0%FY 2023: 0.0%
FY 2019 5y median 0.0% FY 2023
Payout Ratio 0.0%
FY 2019: 0.0%FY 2020: 0.0%FY 2021: 0.0%FY 2022: 0.0%FY 2023: 0.0%
FY 2019 5y median 0.0% FY 2023

Annual · latest fiscal year ends 2023-12-31